The immunohistochemistry results confirmed the SHMT2 knockdown efficiency in the tumor tissue, and the HIF1α staining results were consistent with the in vitro findings, indicating that the HIF1α in the shSHMT2 group was not normally expressed during tumor hypoxia. The gene discussed is HIF1A; the disease is neoplasm.